Digestive Disease Interventions 2022; 06(02): 148-154
DOI: 10.1055/s-0041-1742214
Review Article

Sarcopenia of Cirrhosis and the Therapeutic Potential of Transjugular Intrahepatic Portosystemic Shunt Creation

Barry Schlansky
1   Division of Gastroenterology and Hepatology, Department of Medicine, Oregon Health and Science University, Portland, Oregon
,
2   Department of Interventional Radiology, Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon
› Institutsangaben
Preview

Abstract

Sarcopenia is a major sequela of cirrhosis, contributing to significant morbidity and mortality. Advances in body composition analysis using medical imaging have begun to identify changes in skeletal muscle and fat that are prognostic of the impact of sarcopenia on medical outcomes in cirrhosis and other pathologies. Recently, observational studies have shown a correlation between transjugular intrahepatic portosystemic shunt (TIPS) creation and a reversal of the progressive muscle loss in cirrhosis. This reversal is also associated with improved clinical outcomes and survival. This review summarizes current understanding of cirrhotic sarcopenia, and discusses the implications of TIPS creation in reversing this process.



Publikationsverlauf

Eingereicht: 17. November 2021

Angenommen: 01. Dezember 2021

Artikel online veröffentlicht:
10. Januar 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA